Chingyuan Li

Chingyuan (Rebecca) Li is currently the Executive Director of Pharmaceutical Development at Erasca, Inc. With over 15 years of experience in the pharmaceutical sector, Chingyuan has held various leadership roles, including Director of Pharmaceutical Development at IGNYTA, where they developed the Entrectinib commercial product. Chingyuan's earlier positions included Director of Formulations at Nastech Pharmaceutical and Drug Product Development at Medicis Pharmaceutical Corporation, where they managed multi-million dollar budgets and coordinated extensive drug development activities. Chingyuan is pursuing a Ph.D. in Pharmaceutics from the University of Minnesota.